Added to YB: 2023-04-25
Pitch date: 2023-04-25
SELB [bullish]
Selecta Biosciences, Inc.
-16.87%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of November 13, 2023, Selecta Biosciences, Inc. was acquired by Cartesian Therapeutics, Inc., in a reverse merger transaction.
Market Cap
$136.8M
Pitch Price
$1.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.22
P/E
-2.75
EV/Sales
1.96
Sector
Biotechnology
Category
N/A
Show full summary:
SELECTA BIOSCIENCES INC (SELB) SELB
A summary for this pitch has not been created yet.
Read full article (0 min)